Results 141 to 150 of about 11,862,425 (370)
Molecular Oncology, EarlyView.PARP inhibitors are used to treat a small subset of prostate cancer patients. These studies reveal that PARP1 activity and expression are different between European American and African American prostate cancer tissue samples. Additionally, different PARP inhibitors cause unique and overlapping transcriptional changes, notably, p53 pathway upregulation.
Moriah L. Cunningham +21 more
wiley +1 more source
Special connections: May 13, 1991 [PDF]
, 1991 Time-sensitive news update to monthly University Hospital ...
Office of Publication Services, Boston University Medical Center
core
Molecular Oncology, EarlyView.This study indicates that Merkel cell carcinoma (MCC) does not originate from Merkel cells, and identifies gene, protein & cellular expression of immune‐linked and neuroendocrine markers in primary and metastatic Merkel cell carcinoma (MCC) tumor samples, linked to Merkel cell polyomavirus (MCPyV) status, with enrichment of B‐cell and other immune cell
Richie Jeremian +10 more
wiley +1 more source
مجله علمسنجی کاسپین, 2017 Background and aim: Citation analysis is one of the important ways to assess the status of utilizing references used by students in writing dissertations.
Saeed Malekmohammadi
doaj
Quantifying publication bias in meta‐analysis
Biometrics, 2018 Lifeng Lin, H. Chu
semanticscholar +1 more source
Managing for change: June 1, 1990 v. 1, no. 1 [PDF]
, 1990 Bi-weekly newsletter of University Hospital's Change Project, provided to managers at the ...
Boston University Medical Center, Office of Publication Services
core
Molecular Oncology, EarlyView.A comprehensive genomic and proteomic analysis of cervical cancer revealed STK11 and STX3 as a potential biomarkers of chemoradiation resistance. Our study demonstrated EGFR as a therapeutic target, paving the way for precision strategies to overcome treatment failure and the DNA repair pathway as a critical mechanism of resistance.
Janani Sambath +13 more
wiley +1 more source
Fads and Fallacies in Psychiatry - By Joel Paris, RCPsych Publications, 2013, £15.00 (pb), 128 pp. ISBN: 9781909726062 [PDF]
, 2014 Philip Timms
openalex +1 more source
Managing for change: November 16, 1990 v. 1, no. 6 [PDF]
, 1990 Bi-weekly newsletter of University Hospital's Change Project, provided to managers at the ...
Boston University Medical Center, Office of Publication Services
core
Emerging role of ARHGAP29 in melanoma cell phenotype switching
Molecular Oncology, EarlyView.This study gives first insights into the role of ARHGAP29 in malignant melanoma. ARHGAP29 was revealed to be connected to tumor cell plasticity, promoting a mesenchymal‐like, invasive phenotype and driving tumor progression. Further, it modulates cell spreading by influencing RhoA/ROCK signaling and affects SMAD2 activity. Rho GTPase‐activating protein
Beatrice Charlotte Tröster +3 more
wiley +1 more source